Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis.
Detection of miRNA expression in intact cells using activatable sensor oligonucleotides.
Design of nanodrugs for miRNA targeting in tumor cells.
Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer.
Sensing miRNA: Signal Amplification by Cognate RISC for Intracellular Detection of miRNA in Live Cells.
In Vivo Detection of miRNA Expression in Tumors Using an Activatable Nanosensor.
MicroRNA Therapy for Lymph Node Metastatic Breast Cancer
Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer.
Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin.
Therapy for Metastatic breast cancer based on micro RNA silencing
In vivo methodology for the discovery and validation of miRNA biomarkers in cancer
MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer.
Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells.